| Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease NV Casteele, M Ferrante, G Van Assche, V Ballet, G Compernolle, ... Gastroenterology 148 (7), 1320-1329. e3, 2015 | 945 | 2015 |
| Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease F Schnitzler, H Fidder, M Ferrante, M Noman, I Arijs, G Van Assche, ... Inflammatory bowel diseases 15 (9), 1295-1301, 2009 | 822 | 2009 |
| Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis D Franchimont, S Vermeire, H El Housni, M Pierik, K Van Steen, T Gustot, ... Gut 53 (7), 987-992, 2004 | 793 | 2004 |
| Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis P Gevaert, N Van Bruaene, T Cattaert, K Van Steen, T Van Zele, F Acke, ... Journal of Allergy and Clinical Immunology 128 (5), 989-995. e8, 2011 | 748 | 2011 |
| Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort F Schnitzler, H Fidder, M Ferrante, M Noman, I Arijs, G Van Assche, ... Gut 58 (4), 492-500, 2009 | 688 | 2009 |
| Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma C Bachert, N Zhang, G Holtappels, L De Lobel, P Van Cauwenberge, ... Journal of allergy and clinical immunology 126 (5), 962-968. e6, 2010 | 450 | 2010 |
| Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, K Van Steen, ... Gut 58 (12), 1612-1619, 2009 | 397 | 2009 |
| Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort study S Vermeire, M Noman, G Van Assche, F Baert, K Van Steen, N Esters, ... Gastroenterology 125 (1), 32-39, 2003 | 390 | 2003 |
| New serological markers in inflammatory bowel disease are associated with complicated disease behaviour M Ferrante, L Henckaerts, M Joossens, M Pierik, S Joossens, N Dotan, ... Gut 56 (10), 1394-1403, 2007 | 368 | 2007 |
| Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases M Pierik, S Joossens, K Van Steen, N Van Schuerbeek, R Vlietinck, ... Inflammatory bowel diseases 12 (1), 1-8, 2006 | 363 | 2006 |
| High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ... Nature genetics 47 (2), 172-179, 2015 | 329 | 2015 |
| Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing T Bessissow, B Lemmens, M Ferrante, R Bisschops, K Van Steen, ... Official journal of the American College of Gastroenterology| ACG 107 (11 …, 2012 | 315 | 2012 |
| Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts KC Lødrup Carlsen, S Roll, KH Carlsen, P Mowinckel, AH Wijga, ... Public Library of Science 7 (8), e43214, 2012 | 298 | 2012 |
| Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q MB McQueen, B Devlin, SV Faraone, VL Nimgaonkar, P Sklar, ... The American Journal of Human Genetics 77 (4), 582-595, 2005 | 298 | 2005 |
| Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment I Arijs, G De Hertogh, K Lemaire, R Quintens, L Van Lommel, K Van Steen, ... PloS one 4 (11), e7984, 2009 | 276 | 2009 |
| Long-term outcome after infliximab for refractory ulcerative colitis M Ferrante, S Vermeire, H Fidder, F Schnitzler, M Noman, G Van Assche, ... Journal of Crohn's and Colitis 2 (3), 219-225, 2008 | 260 | 2008 |
| Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy F Schnitzler, H Fidder, M Ferrante, V Ballet, M Noman, G Van Assche, ... Inflammatory bowel diseases 17 (9), 1846-1854, 2011 | 237 | 2011 |
| Travelling the world of gene–gene interactions K Van Steen Briefings in bioinformatics 13 (1), 1-19, 2012 | 214 | 2012 |
| Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma C Bachert, K Van Steen, N Zhang, G Holtappels, T Cattaert, B Maus, ... Journal of allergy and clinical immunology 130 (2), 376-381. e8, 2012 | 211 | 2012 |
| Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease Z Wei, W Wang, J Bradfield, J Li, C Cardinale, E Frackelton, C Kim, ... The American Journal of Human Genetics 92 (6), 1008-1012, 2013 | 205 | 2013 |
